Conferences
15–16 February 2018, Manchester, UK
13th Annual Biomarkers Congress
Oxford Global is proud to present the 13th Annual Biomarkers Congress to be held on 15-16 February 2018 in Manchester.
The congress covers novel developments in biomarker discovery and validation, translation into the clinic, personalised healthcare, Big data management, clinical diagnostics development. Key therapeutic focus areas include Immuno Oncology, Neuroscience, Respiratory, Metabolic and Cardiovascular Diseases.
Attended by over 300 biomarker experts, congress will include representatives from the companies including Bayer, Roche, Merck, UCB, Pfizer. The high quality and outstanding interactive programme includes 2 pre-event webinars, 50 expert presentations, a workshop and 8 round table discussions.
Do not miss out on the latest developments in biomarker innovations, state of the art technologies, and drivers into biomarker development such as precision medicine, immuno-assays and screening processes, histology, immunohistochemistry, big data analytics, new technologies in translation and the prediction of patient population.
View the Agenda here: http://bit.ly/2v4APod
Free Pre-Congress Live Webinar
Predictive and Efficacy Biomarkers in Cancer Research
Tuesday 28th November 2018 | 10am GMT
Hosted by Mattias Bergqvist, VP Clinical Development, Biovica International and Sue Burchill, Professor of Adolescent and Paediatric Cancer Research, Leeds Institute of Cancer and Pathology.
Register today for free: http://bit.ly/2xT7TR9
Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.
For further information, prices & discounts please contact [email protected]
